Literature DB >> 17429198

Effects of haemodialysis on circulating endothelial progenitor cell count.

Alessio Sturiale1, Giuseppe Coppolino, Saverio Loddo, Manila Criseo, Susanna Campo, Eleonora Crascì, Davide Bolignano, Lorena Nostro, Diana Teti, Michele Buemi.   

Abstract

During haemodialysis (HD) the endothelium is the first organ to sense and to be impaired by mechanical and immunological stimuli. We hypothesized that a single HD session induces mobilization of endothelial progenitor cells (EPCs) and that cardiovascular risk factors may influence this process. We quantified EPCs at different maturational stages (CD34+, CD133+/VEGFR2+) in blood samples from 30 patients, during HD and on the interdialytic day, and in 10 healthy volunteers. Samples were drawn at the start of HD, 1, 2 and 3 h after, at the end of HD and at 24 h on the interdialytic day. Patients were divided into two groups based on a recent risk scoring system (SCORE project): low-risk (LR) and high-risk groups (HR). HD patients showed a significantly reduced basal number of EPCs with respect to healthy volunteers. In contrast, we observed increasing EPCs during HD whereas they diminished on the interdialytic day. The EPC number was directly correlated with HD time progression. The EPC number during HD was increased in the HR group with respect to the LR group. We had a direct correlation between risk score and number of EPCs. Cardiovascular risk factors influenced the mobilization of stem cells from the bone marrow. This feature could be the direct consequence of an augmented request of stem cells to respond to the most important endothelial impairment but could also show a defective capacity of EPCs to home in and repair the sites of vascular injury. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429198     DOI: 10.1159/000101697

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  4 in total

1.  Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease.

Authors:  Guido Krenning; Patricia Y W Dankers; Johannes W Drouven; Femke Waanders; Casper F M Franssen; Marja J A van Luyn; Martin C Harmsen; Eliane R Popa
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-01

Review 2.  Endothelial progenitor cells in neovascularization of infarcted myocardium.

Authors:  Kentaro Jujo; Masaaki Ii; Douglas W Losordo
Journal:  J Mol Cell Cardiol       Date:  2008-08-22       Impact factor: 5.000

3.  Circulating endothelial progenitor cells in kidney transplant patients.

Authors:  Giovana S Di Marco; Peter Rustemeyer; Marcus Brand; Raphael Koch; Dominik Kentrup; Alexander Grabner; Burkhard Greve; Werner Wittkowski; Hermann Pavenstädt; Martin Hausberg; Stefan Reuter; Detlef Lang
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

4.  Pleiotropic effect of erythropoiesis-stimulating agents on circulating endothelial progenitor cells in dialysis patients.

Authors:  Takashi Naito; Manabe Shun; Hideki Nishimura; Tomoki Gibo; Mai Tosaka; Moe Kawashima; Akitoshi Ando; Tetsuya Ogawa; Tsutomu Sanaka; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2021-06-09       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.